Michael L. Watkins

Statistics

Publications

Citations

1.8K

H-Index

Active since

2001

Affiliations

GlaxoSmithKline (United States)(Current)

Research Triangle Park Foundation

GlaxoSmithKline (United Kingdom)

Ciro

University of Manchester

Michael L. Watkins is an author at GlaxoSmithKline (United States) specializing in pulmonology, chronic obstructive pulmonary disease, and obstructive lung disease.

ORCID

Publications per year

2001–2020

Publications

Six-Minute-Walk Test in Chronic Obstructive Pulmonary Disease

Michael I. Polkey, Martijn A. Spruit, Lisa Edwards et al. · American Journal of Respiratory and Critical Care Medicine · 2012 · 328 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +16

Determinants of Depression in the ECLIPSE Chronic Obstructive Pulmonary Disease Cohort

Nicola A. Hanania, Hana Müllerová, Nicholas Locantore et al. · American Journal of Respiratory and Critical Care Medicine · 2010 · 318 citations

Medicine, Clinical Sciences, Internal Medicine +16

Predicting Outcomes from 6-Minute Walk Distance in Chronic Obstructive Pulmonary Disease

Martijn A. Spruit, Michael I. Polkey, Bartolomé R. Celli et al. · Journal of the American Medical Directors Association · 2011 · 231 citations

Medicine, Physical Education, Pulmonary Function Testing +13

Determinants of poor 6-min walking distance in patients with COPD: The ECLIPSE cohort

Martijn A. Spruit, Michael L. Watkins, Lisa Edwards et al. · Respiratory Medicine · 2010 · 209 citations · Full text

Education, Physical Education, Physical Activity +10

Efficacy of umeclidinium/vilanterol versus umeclidinium and salmeterol monotherapies in symptomatic patients with COPD not receiving inhaled corticosteroids: the EMAX randomised trial

François Maltais, Leif Bjermer, Edward Kerwin et al. · Respiratory Research · 2019 · 125 citations · Full text

Pharmacy, Clinical Sciences, Pharmacotherapy +17

1–5 of 18